DCTH
Delcath Systems, Inc.
Price Chart
Latest Quote
$11.69
-0.24 (-2.01%)
Current Price
| Previous Close | $11.93 |
| Open | $12.12 |
| Day High | $12.18 |
| Day Low | $11.64 |
| Volume | 582,710 |
Stock Information
| Shares Outstanding | 34.52M |
| Total Debt | $907K |
| Cash Equivalents | $89.30M |
| Revenue | $90.44M |
| Net Income | $561K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $403.56M |
| P/E Ratio | 1169.00 |
| EPS (TTM) | $0.01 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $315.17M |
| Sales | $90.44M |
| Income | $561K |
| Book/sh | $3.27 |
| Cash/sh | $2.59 |
| Employees | 156 |
Financial Ratios
| Quick Ratio | 9.72 |
| Current Ratio | 11.24 |
| Debt/Eq | 0.81 |
Returns & Margins
| ROA | -0.95% |
| ROE | 0.58% |
| Gross Margin | 85.97% |
| Operating Margin | -6.55% |
| Profit Margin | 0.62% |
Ownership
| Insider Ownership | 8.13% |
| Institutional Ownership | 48.92% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -22.92 |
| PEG | 1.60 |
| P/S | 4.46 |
| P/B | 3.57 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $21.35 |
Technical Indicators
| SMA20 | $11.16 |
| SMA50 | $11.01 |
| SMA200 | $10.24 |
| RSI | 61.04 |
| ATR | 0.6163 |
| Shares Float | 28.60M |
| Short Float | 9.81% |
| Short Ratio | 6.54 |
| Volatility | 0.52 |
| Rel Volume | 1.03 |
Performance History
| Week | -0.64% |
| Month | +7.74% |
| Quarter | +25.16% |
| 6 Months | +16.55% |
| YTD | +17.49% |
| Year | -20.10% |
| 3 Years | +69.18% |
| 5 Years | -1.52% |
| 10 Years | -98.76% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $11.69 | 582,700 |
| 2026-06-17 | $11.93 | 727,000 |
| 2026-06-16 | $11.54 | 430,900 |
| 2026-06-15 | $11.79 | 449,500 |
| 2026-06-12 | $11.72 | 299,600 |
| 2026-06-11 | $11.77 | 809,000 |
| 2026-06-10 | $11.19 | 600,100 |
| 2026-06-09 | $11.69 | 1,043,900 |
| 2026-06-08 | $10.94 | 1,200,300 |
| 2026-06-05 | $10.67 | 588,200 |
| 2026-06-04 | $10.79 | 415,400 |
| 2026-06-03 | $10.33 | 400,300 |
| 2026-06-02 | $10.53 | 531,200 |
| 2026-06-01 | $10.60 | 598,000 |
| 2026-05-29 | $10.78 | 421,700 |
| 2026-05-28 | $10.95 | 483,400 |
| 2026-05-27 | $10.91 | 586,900 |
| 2026-05-26 | $10.83 | 553,900 |
| 2026-05-22 | $11.02 | 274,700 |
| 2026-05-21 | $11.45 | 355,400 |
| 2026-05-20 | $11.23 | 623,500 |
| 2026-05-19 | $10.85 | 255,000 |
About Delcath Systems, Inc.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. The company also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. The company was founded in 1988 and is headquartered in Queensbury, New York.
đ° Latest News
Delcath (DCTH) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-08T16:25:55Z
Delcath Systems Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-07T17:42:42Z
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-07T15:15:04Z
How The Delcath Systems (DCTH) Story Is Shifting With Hepzato Milestones And 2026 Guidance
Simply Wall St. âĸ 2026-05-01T09:20:39Z
Implied Volatility Surging for Delcath Systems Stock Options
Zacks âĸ 2026-04-07T14:06:00Z
Delcath Systems publishes results from CHOPIN trial in The Lancet Oncology
TipRanks âĸ 2026-03-04T13:43:26Z
Delcath Systems Inc (DCTH) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...
GuruFocus.com âĸ 2026-02-26T21:09:42ZDelcath Systems Q4 Earnings Call Highlights
MarketBeat âĸ 2026-02-26T20:48:24Z
Delcath (DCTH) Q4 2025 Earnings Call Transcript
Motley Fool âĸ 2026-02-26T15:33:26Z
Delcath Systems, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-26T13:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $11,797,000 | $6,188,000 | $635,000 | $686,000 |
| Cost Of Revenue | $11,797,000 | $6,188,000 | $635,000 | $686,000 |
| Total Revenue | $85,231,000 | $37,205,000 | $2,065,000 | $2,719,000 |
| Operating Revenue | $85,231,000 | $37,205,000 | $2,065,000 | $2,548,000 |
| Expenses | ||||
| Total Expenses | $84,571,000 | $49,615,000 | $40,247,000 | $36,572,000 |
| Other Income Expense | $-70,000 | $-14,101,000 | $-8,057,000 | $30,000 |
| Other Non Operating Income Expenses | $-70,000 | $-30,000 | $-59,000 | $30,000 |
| Net Non Operating Interest Income Expense | $2,920,000 | $125,000 | $-1,439,000 | $-2,685,000 |
| Total Other Finance Cost | $-2,920,000 | $-125,000 | $1,439,000 | - |
| Operating Expense | $72,774,000 | $43,427,000 | $39,612,000 | $35,886,000 |
| Interest Expense | - | - | $1,439,000 | $2,685,000 |
| Interest Expense Non Operating | - | - | $1,439,000 | $2,685,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Net Interest Income | $2,920,000 | $125,000 | $-1,439,000 | $-2,685,000 |
| Normalized Income | $2,700,000 | $-12,315,000 | $-39,680,000 | $-36,508,000 |
| Net Income From Continuing And Discontinued Operation | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Total Operating Income As Reported | $660,000 | $-12,410,000 | $-38,182,000 | $-33,853,000 |
| Net Income Common Stockholders | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Net Income | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Net Income Including Noncontrolling Interests | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Net Income Continuous Operations | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Pretax Income | $3,510,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Operating Income | $660,000 | $-12,410,000 | $-38,182,000 | $-33,853,000 |
| Gross Profit | $73,434,000 | $31,017,000 | $1,430,000 | $2,033,000 |
| Per Share | ||||
| Diluted EPS | $0.07 | $-0.93 | $-2.94 | $-4.12 |
| Basic EPS | $0.08 | $-0.93 | $-2.94 | $-4.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $1,009,000 | $1,890,000 | $-29,785,000 | $-33,691,000 |
| Reconciled Depreciation | $349,000 | $229,000 | $399,000 | $132,000 |
| EBITDA (Bullshit earnings) | $1,009,000 | $-12,181,000 | $-37,783,000 | $-33,691,000 |
| EBIT | $660,000 | $-12,410,000 | $-38,182,000 | $-33,823,000 |
| Diluted Average Shares | $35,821,157 | $28,511,393 | $16,229,931 | $16,229,931 |
| Basic Average Shares | $35,821,157 | $28,511,393 | $16,229,931 | $16,229,931 |
| Diluted NI Availto Com Stockholders | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Tax Provision | $810,000 | $0 | - | - |
| Research And Development | $29,246,000 | $13,874,000 | $17,502,000 | $18,583,000 |
| Selling General And Administration | $43,528,000 | $29,553,000 | $22,110,000 | $17,303,000 |
| Total Unusual Items | - | $-14,071,000 | $-7,998,000 | - |
| Total Unusual Items Excluding Goodwill | - | $-14,071,000 | $-7,998,000 | - |
| Gain On Sale Of Security | - | $-14,071,000 | $-7,998,000 | - |
| Otherunder Preferred Stock Dividend | - | - | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $111,219,000 | $68,746,000 | $15,777,000 | $-5,859,000 |
| Total Assets | $123,632,000 | $76,589,000 | $38,613,000 | $17,862,000 |
| Total Non Current Assets | $4,102,000 | $2,829,000 | $1,455,000 | $1,707,000 |
| Current Assets | $119,530,000 | $73,760,000 | $37,158,000 | $16,155,000 |
| Other Current Assets | $1,547,000 | $1,389,000 | $337,000 | $95,000 |
| Prepaid Assets | $3,756,000 | $1,145,000 | $512,000 | $1,874,000 |
| Inventory | $10,252,000 | $6,933,000 | $3,322,000 | $1,998,000 |
| Receivables | $12,939,000 | $11,060,000 | $483,000 | $366,000 |
| Taxes Receivable | $696,000 | $45,000 | $91,000 | - |
| Accrued Interest Receivable | $499,000 | $125,000 | $151,000 | $0 |
| Accounts Receivable | $11,744,000 | $10,890,000 | $241,000 | $366,000 |
| Cash Cash Equivalents And Short Term Investments | $91,036,000 | $53,233,000 | $32,454,000 | $7,671,000 |
| Cash And Cash Equivalents | $43,454,000 | $32,412,000 | $12,646,000 | $7,671,000 |
| Restricted Cash | - | $0 | $50,000 | $4,151,000 |
| Debt | ||||
| Total Debt | $936,000 | $1,038,000 | $10,187,000 | $15,874,000 |
| Long Term Debt And Capital Lease Obligation | $835,000 | $933,000 | $0 | $7,842,000 |
| Current Debt And Capital Lease Obligation | $101,000 | $105,000 | $10,187,000 | $8,032,000 |
| Current Debt | - | - | $10,150,000 | $7,846,000 |
| Other Current Borrowings | - | - | $10,150,000 | $7,846,000 |
| Net Debt | - | - | - | $8,017,000 |
| Long Term Debt | - | - | - | $7,842,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,413,000 | $7,843,000 | $22,836,000 | $23,721,000 |
| Total Non Current Liabilities Net Minority Interest | $1,463,000 | $1,699,000 | $6,388,000 | $8,986,000 |
| Other Non Current Liabilities | $628,000 | $766,000 | $840,000 | $1,144,000 |
| Current Liabilities | $10,950,000 | $6,144,000 | $16,448,000 | $14,735,000 |
| Payables And Accrued Expenses | $6,205,000 | $2,328,000 | $4,327,000 | $5,663,000 |
| Payables | $2,658,000 | $961,000 | $1,012,000 | $2,018,000 |
| Accounts Payable | $2,658,000 | $961,000 | $1,012,000 | $2,018,000 |
| Derivative Product Liabilities | - | $0 | $5,548,000 | $0 |
| Interest Payable | - | $0 | $713,000 | $553,000 |
| Current Deferred Liabilities | - | - | - | $1,470,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $111,219,000 | $68,746,000 | $15,777,000 | $-5,859,000 |
| Total Equity Gross Minority Interest | $111,219,000 | $68,746,000 | $15,777,000 | $-5,859,000 |
| Stockholders Equity | $111,219,000 | $68,746,000 | $15,777,000 | $-5,859,000 |
| Gains Losses Not Affecting Retained Earnings | $575,000 | $82,000 | $135,000 | $-83,000 |
| Other Equity Adjustments | $575,000 | $82,000 | $135,000 | $-83,000 |
| Retained Earnings | $-528,848,000 | $-531,548,000 | $-505,162,000 | $-457,484,000 |
| Other | ||||
| Ordinary Shares Number | $34,691,671 | $33,061,002 | $22,761,554 | $10,046,571 |
| Share Issued | $34,691,671 | $33,061,002 | $22,761,554 | $10,046,571 |
| Tangible Book Value | $111,219,000 | $68,746,000 | $15,777,000 | $-5,859,000 |
| Invested Capital | $111,219,000 | $68,746,000 | $25,927,000 | $9,829,000 |
| Capital Lease Obligations | $936,000 | $1,038,000 | $37,000 | $186,000 |
| Total Capitalization | $111,219,000 | $68,746,000 | $15,777,000 | $1,983,000 |
| Additional Paid In Capital | $639,145,000 | $599,881,000 | $520,576,000 | $451,608,000 |
| Capital Stock | $347,000 | $331,000 | $228,000 | $100,000 |
| Common Stock | $347,000 | $331,000 | $228,000 | $100,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $835,000 | $933,000 | $0 | - |
| Current Capital Lease Obligation | $101,000 | $105,000 | $37,000 | $186,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $4,644,000 | $3,711,000 | $1,934,000 | $1,040,000 |
| Current Accrued Expenses | $3,547,000 | $1,367,000 | $3,315,000 | $3,645,000 |
| Net PPE | $4,102,000 | $2,829,000 | $1,455,000 | $1,707,000 |
| Accumulated Depreciation | $-5,248,000 | $-4,954,000 | $-5,075,000 | $-4,931,000 |
| Gross PPE | $9,350,000 | $7,783,000 | $6,530,000 | $6,638,000 |
| Leases | $1,648,000 | $1,585,000 | $1,787,000 | $1,774,000 |
| Construction In Progress | $245,000 | $127,000 | $0 | - |
| Other Properties | $3,830,000 | $2,710,000 | $1,366,000 | $1,507,000 |
| Machinery Furniture Equipment | $2,070,000 | $2,043,000 | $2,059,000 | $2,056,000 |
| Buildings And Improvements | $1,557,000 | $1,318,000 | $1,318,000 | $1,301,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $966,000 | $824,000 | $126,000 | $133,000 |
| Work In Process | $2,809,000 | $2,260,000 | $1,753,000 | $1,102,000 |
| Raw Materials | $6,477,000 | $3,849,000 | $1,443,000 | $763,000 |
| Other Short Term Investments | $47,582,000 | $20,821,000 | $19,808,000 | $0 |
| Treasury Shares Number | - | - | $0 | - |
| Current Deferred Revenue | - | - | - | $0 |
| Non Current Deferred Revenue | - | - | - | - |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $20,969,000 | $-19,240,000 | $-31,309,000 | $-25,159,000 |
| Operating Activities | ||||
| Operating Cash Flow | $22,516,000 | $-18,681,000 | $-31,251,000 | $-24,950,000 |
| Cash Flow From Continuing Operating Activities | $22,516,000 | $-18,681,000 | $-31,251,000 | $-24,950,000 |
| Operating Gains Losses | - | $14,071,000 | $7,998,000 | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,547,000 | $-559,000 | $-58,000 | $-209,000 |
| Investing Cash Flow | $-26,590,000 | $-981,000 | $-19,709,000 | $-209,000 |
| Cash Flow From Continuing Investing Activities | $-26,590,000 | $-981,000 | $-19,709,000 | $-209,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-6,000,000 | $0 | - | - |
| Issuance Of Capital Stock | $481,000 | $7,021,000 | $23,083,000 | $10,857,000 |
| Financing Cash Flow | $15,048,000 | $39,410,000 | $51,778,000 | $10,143,000 |
| Cash Flow From Continuing Financing Activities | $15,048,000 | $39,410,000 | $51,778,000 | $10,143,000 |
| Net Common Stock Issuance | $-5,519,000 | $7,021,000 | $23,083,000 | $10,857,000 |
| Common Stock Issuance | $481,000 | $7,021,000 | $23,083,000 | $10,857,000 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-10,610,000 | $-6,313,000 | $-714,000 |
| Interest Paid Supplemental Data | $0 | $1,236,000 | $1,459,000 | $1,873,000 |
| Income Tax Paid Supplemental Data | $1,545,000 | $0 | - | - |
| End Cash Position | $43,454,000 | $32,412,000 | $12,696,000 | $11,822,000 |
| Beginning Cash Position | $32,412,000 | $12,696,000 | $11,822,000 | $26,953,000 |
| Effect Of Exchange Rate Changes | $68,000 | $-32,000 | $56,000 | $-115,000 |
| Changes In Cash | $10,974,000 | $19,748,000 | $818,000 | $-15,016,000 |
| Proceeds From Stock Option Exercised | $20,567,000 | $42,999,000 | $35,008,000 | $0 |
| Common Stock Payments | $-6,000,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $0 | $-10,610,000 | $-6,313,000 | $-714,000 |
| Net Long Term Debt Issuance | $0 | $-10,610,000 | $-6,313,000 | $-714,000 |
| Long Term Debt Payments | $0 | $-10,610,000 | $-6,313,000 | $-714,000 |
| Net Investment Purchase And Sale | $-25,043,000 | $-422,000 | $-19,651,000 | $0 |
| Sale Of Investment | $68,173,000 | $52,031,000 | $0 | $0 |
| Purchase Of Investment | $-93,216,000 | $-52,453,000 | $-19,651,000 | $0 |
| Net PPE Purchase And Sale | $-1,547,000 | $-559,000 | $-58,000 | $-209,000 |
| Purchase Of PPE | $-1,547,000 | $-559,000 | $-58,000 | $-209,000 |
| Interest Paid Cfo | $0 | $-847,000 | $0 | - |
| Change In Working Capital | $-3,069,000 | $-15,521,000 | $-906,000 | $2,114,000 |
| Change In Other Current Liabilities | $-241,000 | $-101,000 | $-537,000 | $621,000 |
| Change In Payables And Accrued Expense | $4,766,000 | $479,000 | $-199,000 | $1,798,000 |
| Change In Payable | $4,766,000 | $479,000 | $-199,000 | - |
| Change In Account Payable | $4,766,000 | $479,000 | $-199,000 | - |
| Change In Prepaid Assets | $-3,421,000 | $-1,639,000 | $1,029,000 | $774,000 |
| Change In Inventory | $-3,319,000 | $-3,611,000 | $-1,324,000 | $-587,000 |
| Change In Receivables | $-854,000 | $-10,649,000 | $125,000 | $-322,000 |
| Changes In Account Receivables | $-854,000 | $-10,649,000 | $125,000 | $-322,000 |
| Stock Based Compensation | $24,232,000 | $9,767,000 | $8,151,000 | $7,941,000 |
| Amortization Of Securities | $-1,696,000 | $-587,000 | $-151,000 | $0 |
| Depreciation Amortization Depletion | $349,000 | $229,000 | $399,000 | $132,000 |
| Depreciation And Amortization | $349,000 | $229,000 | $399,000 | $132,000 |
| Depreciation | $349,000 | $229,000 | $399,000 | $132,000 |
| Net Income From Continuing Operations | $2,700,000 | $-26,386,000 | $-47,678,000 | $-36,508,000 |
| Other Non Cash Items | - | $593,000 | $936,000 | $1,371,000 |
| Gain Loss On Investment Securities | - | $14,071,000 | $7,998,000 | - |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Change In Other Working Capital | - | - | - | $-170,000 |
| Change In Accrued Expense | - | - | - | - |
Fetched: 2026-06-17